PhiTech Bioinformatics
Date | Investors | Amount | Round |
---|---|---|---|
* | $3.0m | Seed | |
* | $250k Valuation: $15.0m | Seed | |
* | $1.1m Valuation: $15.0m | Seed | |
Total Funding | $4.4m |
Recent News about PhiTech Bioinformatics
EditPHITECH, founded in 2013, specializes in bioinformatics, integrating life sciences and computer sciences to provide advanced solutions for precision medicine, agrigenomics, and the bio industry. The company serves scientists, clinicians, and biotech specialists by translating large-scale biological data into actionable insights. PHITECH's core business involves applying cutting-edge algorithms to genome-wide molecular data, including genomics, transcriptomics, epigenomics, and microbiomics, to enhance diagnostic decision-making. Operating in the rapidly evolving bioinformatics market, PHITECH generates revenue through service contracts, research collaborations, and technology licensing. The company's mission is to accelerate the transition from scientific discoveries to technological applications, ultimately benefiting humanity.
Keywords: bioinformatics, genomics, transcriptomics, epigenomics, microbiomics, precision medicine, agrigenomics, biotech, algorithms, diagnostics.